Market Access

Jazz and Lilly cancer drugs cleared for use by NHS

Pharmaphorum

Jazz's biliary tract cancer drug Ziihera and Lilly's Jaypirca for chronic lymphocytic leukaemia have been backed for NHS use in new NICE guidance.

Market Access Oncology Read full story

pharminent April 21, 2026 (Last updated: April 21, 2026)

Pharmaphorum

Jazz’s biliary tract cancer drug Ziihera and Lilly’s Jaypirca for chronic lymphocytic leukaemia have been backed for NHS use in new NICE guidance.

Market Access Oncology Read full story